
Nigeria: Critical AMR Policy Implementation Gaps Identified
Summary
- Pharmacist Folashade Lawal highlighted Nigeria's significant challenges in implementing antimicrobial resistance policies despite having established guidelines.
- An assessment of Nigeria's first National Action Plan on AMR (2017-2022) revealed only 44% completion, citing gaps in coordination, funding, and cross-sectoral implementation.
- Nigeria's second One Health National Action Plan on AMR (2024-2028) aims to address these issues through stronger governance, surveillance, and responsible antimicrobial use.
- Antimicrobial resistance was linked to approximately 4.7 million global deaths in 2021, including an estimated 50,500 direct deaths in Nigeria.
- Experts advocate for stronger enforcement of antimicrobial sales regulations, sustainable funding, improved diagnostics, and expanded public awareness to combat this "silent pandemic."
Nigeria's Policy Implementation Challenge
Ms. Lawal issued a stark warning that the unchecked spread of resistance not only jeopardizes the treatment of common infections but also poses a severe threat to advanced medical procedures.
Pharmacist Folashade Lawal, who serves as the managing director and chief executive officer of Victory Drugs, recently highlighted a critical shortfall in Nigeria's efforts to combat antimicrobial resistance (AMR). She observed that despite the nation's official commitments to policy, routine antimicrobial stewardship activities remain largely absent across numerous healthcare institutions. Lawal underscored that while Nigeria has successfully developed comprehensive policies and guidelines aimed at addressing AMR, the primary hurdle now lies in their effective implementation within healthcare facilities and local communities.
These remarks were delivered during the ninth Ladipo Mobolaji Abisogun-Afodu Annual Lecture in Pharmacy, hosted at the College of Medicine, University of Lagos. The lecture, titled "Addressing Antimicrobial Stewardship in Nigeria: Current Perspectives and Future Imperatives," coincided with the 2026 World Antimicrobial Resistance Awareness Week, an observance held annually from November 18 to 24. Lawal emphasized that the current challenge is not about planning new strategies but rather about executing the existing ones.
National Action Plans and Identified Shortcomings
Nigeria's initial strategic response to antimicrobial resistance was outlined in its first National Action Plan on AMR, which spanned the period from 2017 to 2022. This foundational plan was designed with the overarching goal of mitigating, preventing, and decelerating the emergence of resistant microorganisms. Its core strategies encompassed public awareness campaigns, robust surveillance systems, stringent infection prevention and control measures, the promotion of responsible antimicrobial usage, and dedicated research initiatives.
However, an subsequent evaluation of this plan's execution revealed significant deficiencies, with only 44 percent of its proposed activities successfully completed. This assessment pointed to substantial gaps in inter-sectoral coordination, financial resource allocation, and overall implementation effectiveness. In response to these findings and the ongoing threat, Nigeria subsequently introduced its second comprehensive strategy, the One Health National Action Plan on AMR, slated for the years 2024 to 2028. This updated plan articulates six key strategic objectives, including strengthening governance structures, enhancing surveillance capabilities, increasing public awareness, improving infection prevention and control, fostering responsible antimicrobial use, and developing research and capacity.
The Grave Consequences of Unchecked Resistance
The urgency of addressing these implementation gaps was further underscored by Ms. Lawal, who characterized antimicrobial resistance as a "silent pandemic" that consistently eroding the efficacy of medications crucial for treating infections. She presented alarming statistics, noting that bacterial antimicrobial resistance was linked to approximately 4.7 million fatalities globally in 2021, with a staggering 1.14 million deaths directly attributable to these resistant infections. The situation in Nigeria is equally concerning, where estimates suggest AMR was directly responsible for 50,500 deaths and associated with around 227,000 deaths during the same year.
Ms. Lawal issued a stark warning that the unchecked spread of resistance not only jeopardizes the treatment of common infections but also poses a severe threat to advanced medical procedures. These include critical interventions such as surgery, cancer therapies, organ transplantation, neonatal care, and intensive care, all of which fundamentally rely on the continued effectiveness of antimicrobial agents. Dean Sunday Adesegun of the University of Lagos's Faculty of Pharmacy echoed these concerns, stating that AMR imperils the successful treatment of infectious diseases and could reverse significant advancements in modern medicine. He specifically cited ongoing challenges within Nigeria, including widespread self-medication, unregulated access to antibiotics, inadequate infection prevention and control protocols, and deficiencies in antimicrobial resistance surveillance.
Calls for Enhanced Enforcement and Investment
To counter these pressing threats, Ms. Lawal advocated for several crucial interventions. She urged for more rigorous enforcement of existing regulations governing the sale of antimicrobial drugs, emphasizing the need for stricter controls. Furthermore, she called for the allocation of sustainable funding to support stewardship programs across federal, state, and institutional levels. Improving access to essential diagnostic services and bolstering laboratory infrastructure were also highlighted as vital steps. She also stressed the imperative of establishing dedicated antimicrobial stewardship programs within all healthcare facilities.
In addition to these measures, Ms. Lawal recommended strengthening the monitoring of antimicrobial consumption patterns, investing significantly in workforce development, and fostering research initiatives. Expanding public awareness campaigns about the responsible use of antimicrobials was also identified as a key strategy. Dean Adesegun reinforced the collective responsibility, asserting that antimicrobial stewardship transcends mere professional duty; it is a shared obligation to safeguard public health, urging all stakeholders to transition from mere awareness to decisive, concrete actions.
Practical Implications
Lawyers and compliance officers in Nigeria's healthcare and pharmaceutical sectors should advise clients to review and strengthen their antimicrobial stewardship programs, anticipating increased regulatory scrutiny and enforcement of existing AMR policies, particularly concerning antimicrobial sales and appropriate prescribing, despite current national implementation gaps.
Source
How does this affect you?
Get an AI analysis of this article grounded in your jurisdictions, practice areas, and any policy documents you've uploaded to Wansom.
Finish Reading the Full Story and the Expert Analysis.
Get the latest legal & regulatory intelligence in Nigeria
Wansom is AI and can make mistakes.
